Impact of Left Ventricular Assist Devices on Days Alive and Out of Hospital in Hemodynamically Stable Patients with End-Stage Heart Failure: A Propensity Score Matched Study

Bibliographic Details
Title: Impact of Left Ventricular Assist Devices on Days Alive and Out of Hospital in Hemodynamically Stable Patients with End-Stage Heart Failure: A Propensity Score Matched Study
Authors: Theresa Tenge, Sebastian Roth, René M‘Pembele, Giovanna Lurati Buse, Florian Boenner, Christina Ballázs, Igor Tudorache, Udo Boeken, Artur Lichtenberg, Martin Neukirchen, Ragnar Huhn, Hug Aubin
Source: Life, Vol 12, Iss 12, p 1966 (2022)
Publisher Information: MDPI AG, 2022.
Publication Year: 2022
Collection: LCC:Science
Subject Terms: heart failure, cardiac surgery, heart transplantation, left ventricular assist devices, patient-centered outcomes, Science
More Details: The two main surgical options to treat end-stage heart failure are heart transplantation (HTx) or left ventricular assist device (LVAD) implantation. In hemodynamically stable patients, the decision for HTx listing with or without LVADs is challenging. We analyzed the impact of both options on days alive and out of hospital (DAOH) and survival. This retrospective study screened all patients with HTx or LVAD implantation between 2010 and 2020. The main inclusion criterion was hemodynamic stability defined as independence of intravenous inotropic/vasoactive support at decision. Propensity score matching (PSM) was performed. The primary endpoint was DAOH within one year after the decision. Secondary endpoints included survival, duration until HTx, and hospitalizations. In total, 187 patients received HTx and 227 patients underwent LVAD implantation. There were 21 bridge-to-transplant (BTT)-LVAD patients (implantation less than a month after HTx listing or listing after implantation) and 44 HTx-waiting patients included. PSM identified 17 matched pairs. Median DAOH at one year was not significantly different between the groups (BTT-LVAD: median 281, IQR 89; HTx waiting: median 329, IQR 74; p = 0.448). Secondary endpoints did not differ significantly. Our data suggest that BTT-LVAD implantation may not be favorable in terms of DAOH within one year for hemodynamically stable patients compared to waiting for HTx. Further investigations on quality of life and long-term outcomes are warranted.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2075-1729
Relation: https://www.mdpi.com/2075-1729/12/12/1966; https://doaj.org/toc/2075-1729
DOI: 10.3390/life12121966
Access URL: https://doaj.org/article/4c53e7b771844dff80c3cc0d67ac82d2
Accession Number: edsdoj.4c53e7b771844dff80c3cc0d67ac82d2
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:20751729
DOI:10.3390/life12121966
Published in:Life
Language:English